Cidara Therapeutics (NASDAQ: CDTX) reported Q4 EPS of ($0.88), versus ($0.72) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.